IFF (NYSE: IFF) — a global leader in flavors, fragrances, food ingredients, health and biosciences — announced a strategic ...

Emerging trends in Healthcare Stocks include increasing adoption of gene therapies, advancements in precision medicine, and ...

Cellexia's Cellular Renewal Cream takes a fundamentally different approach. Instead of just smoothing existing wrinkles or ...

In the hunt for new therapeutics for cancer and infectious diseases, lasso peptides prove to be a catch. Their knot-like ...

Researchers have made a significant advance toward the goal of using bacteria—rather than fossil fuels—to produce ethylene, a ...

Proteins sourced from microorganisms are attracting attention for their potential in biomanufacturing a variety of products, ...

"We are very excited about the collaboration with BASF to jointly unlock new potential in enzyme and polymer technologies," ...

Abdominal pain is a hallmark of many digestive disorders, including inflammatory bowel disease and irritable bowel syndrome. In an effort to develop targeted treatments for gut pain, scientists have ...

Halide perovskites—already a focus of major research into efficient, low-cost solar cells—have been shown to handle light ...

"We are very pleased to be collaborating with BASF to jointly unlock new potential in enzyme and polymer technology," explains Erik Fyrwald, CEO of IFF. This partnership enables us to develop ...

Oct 21, 2025–Integrated DNA Technologies (IDT), a Danaher company and a global leader in genomics, and Profluent Bio, a ...